title: Uncovering early, lineage-dependent effects of TPMT genotype in adult acute lymphoblastic leukemia by minimal residual disease.
authors.forename: T
authors.initials: T
authors.lastname: Raff
authors.forename: M
authors.initials: M
authors.lastname: Kaiser
authors.forename: N
authors.initials: N
authors.lastname: Gökbuget
authors.forename: S
authors.initials: S
authors.lastname: Lüschen
authors.forename: M
authors.initials: M
authors.lastname: Ritgen
authors.forename: H
authors.initials: H
authors.lastname: Trautmann
authors.forename: R
authors.initials: R
authors.lastname: Reutzel
authors.forename: D
authors.initials: D
authors.lastname: Hoelzer
authors.forename: M
authors.initials: M
authors.lastname: Kneba
authors.forename: M
authors.initials: M
authors.lastname: Brüggemann
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D019070:Cell Lineage; D005260:Female; D005838:Genotype; D006801:Humans; D008297:Male; D008780:Methyltransferases / Q000235:genetics*; D018365:Neoplasm, Residual; D016133:Polymerase Chain Reaction; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology
chemical_list: D008780:Methyltransferases; C022745:thiopurine methyltransferase